OTCMKTS
GNRS

Greenrose Acquisition Corp

Drug Manufacturers-Specialty & Generic
Healthcare

Prices are adjusted according to historical splits.

Greenrose Acquisition Corp Stock Price

Vitals

Today's Low:
$0.02
Today's High:
$0.02
Open Price:
$0.02
52W Low:
$0.001
52W High:
$2.13
Prev. Close:
$0.02
Volume:
0

Company Statistics

Market Cap.:
$353680
Book Value:
0.822
Revenue TTM:
$28.40 million
Operating Margin TTM:
-145.92%
Gross Profit TTM:
$18.68 million
Profit Margin:
47.38%
Return on Assets TTM:
-14.78%
Return on Equity TTM:
34.62%

Company Profile

Greenrose Acquisition Corp had its IPO on 2020-05-21 under the ticker symbol GNRS.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Greenrose Acquisition Corp has a staff strength of 91 employees.

Stock update

Shares of Greenrose Acquisition Corp opened at $0.02 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.02 - $0.02, and closed at $0.02.

This is a 0% increase from the previous day's closing price.

A total volume of 0 shares were traded at the close of the day’s session.

In the last one week, shares of Greenrose Acquisition Corp have increased by 0%.

Greenrose Acquisition Corp's Key Ratios

Greenrose Acquisition Corp has a market cap of $353680, indicating a price to book ratio of 0.4811 and a price to sales ratio of 0.2525.

In the last 12-months Greenrose Acquisition Corp’s revenue was $28.40 million with a gross profit of $18.68 million and an EBITDA of $-11528000. The EBITDA ratio measures Greenrose Acquisition Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Greenrose Acquisition Corp’s operating margin was -145.92% while its return on assets stood at -14.78% with a return of equity of 34.62%.

In Q3, Greenrose Acquisition Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 25.9%.

Greenrose Acquisition Corp’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Greenrose Acquisition Corp’s profitability.

Greenrose Acquisition Corp stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -30.8837. Its price to sales ratio in the trailing 12-months stood at 0.2525.

Greenrose Acquisition Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$175.77 million
Total Liabilities
$151.06 million
Operating Cash Flow
$202000.00
Capital Expenditure
$183000
Dividend Payout Ratio
0%

Greenrose Acquisition Corp ended 2024 with $175.77 million in total assets and $0 in total liabilities. Its intangible assets were valued at $175.77 million while shareholder equity stood at $14.53 million.

Greenrose Acquisition Corp ended 2024 with $1.00 million in deferred long-term liabilities, $151.06 million in other current liabilities, 2000.00 in common stock, $-62717000.00 in retained earnings and $32.64 million in goodwill. Its cash balance stood at $962000.00 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $9.57 million.

Greenrose Acquisition Corp’s total current assets stands at $15.43 million while long-term investments were $0 and short-term investments were $0.00. Its net receivables were $1.95 million compared to accounts payable of $4.62 million and inventory worth $11.88 million.

In 2024, Greenrose Acquisition Corp's operating cash flow was $202000.00 while its capital expenditure stood at $183000.

Comparatively, Greenrose Acquisition Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.02
52-Week High
$2.13
52-Week Low
$0.001
Analyst Target Price
$

Greenrose Acquisition Corp stock is currently trading at $0.02 per share. It touched a 52-week high of $2.13 and a 52-week low of $2.13. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.13 and 200-day moving average was $0.36 The short ratio stood at 2.8 indicating a short percent outstanding of 0%.

Around 7175.2% of the company’s stock are held by insiders while 1515.2% are held by institutions.

Frequently Asked Questions About Greenrose Acquisition Corp

The stock symbol (also called stock or share ticker) of Greenrose Acquisition Corp is GNRS

The IPO of Greenrose Acquisition Corp took place on 2020-05-21

Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)

Last Price
Chg
Chg%
Kahoot As (KHOTF)
$3.23
-0.02
-0.62%
$159.78
1.7
+1.08%
Docebo Inc (DCBO)
$40.38
-0.74
-1.8%
Navient Corp (NAVI)
$17.36
0.09
+0.52%
$484.75
-17.3
-3.45%
QVCC (QVCC)
$10.07
-0.29
-2.84%
$2926.8
84.45
+2.97%
WEG SA ADR (WEGZY)
$7.08
-0.04
-0.56%
$127.25
-8.4
-6.19%
$1990.85
-19.65
-0.98%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Greenrose Holding Company Inc., through its subsidiaries, engages in the production and sale of cannabis products. It engages in cultivating, processing, and packaging medical cannabis and derivative products. The company was founded in 2014 and is headquartered in Amityville, New York.

Address

111 Broadway, Amityville, NY, United States, 11701